(Q50552508)

English

Efficacy of the regimen using twice-daily β-interferon followed by the standard of care for chronic hepatitis C genotype 1b with high viral load.

scientific article published on 4 April 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/22487191

Efficacy of the regimen using twice-daily β-interferon followed by the standard of care for chronic hepatitis C genotype 1b with high viral load. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/22487191

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

author name string

Toru Ishikawa

1

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/22487191

Tomoyuki Kubota

2

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/22487191

Hiroyuki Abe

3

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/22487191

Aiko Nagashima

4

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/22487191

Kanae Hirose

5

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/22487191

Tadayuki Togashi

6

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/22487191

Keiichi Seki

7

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/22487191

Terasu Honma

8

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/22487191

Toshiaki Yoshida

9

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/22487191

Tomoteru Kamimura

10

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/22487191

publication date

4 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/22487191

Hepatology Research

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/22487191

42

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/22487191

9

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/22487191

864-869

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/22487191

Hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.00995.X

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.00995.X

21 January 2018

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.00995.X

21 January 2018

Early clearance of circulating hepatitis C virus enhanced by induction therapy with twice-a-day intravenous injection of IFN-beta

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.00995.X

21 January 2018

Different turnover rate of hepatitis C virus clearance by different treatment regimen using interferon-beta

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.00995.X

21 January 2018

A potent antiviral effect on hepatitis C viral dynamics in serum and peripheral blood mononuclear cells during combination therapy with high-dose daily interferon alfa plus ribavirin and intravenous twice-daily treatment with interferon beta

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.00995.X

21 January 2018

Interferon-stimulated gene expression and hepatitis C viral dynamics during different interferon regimens

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.00995.X

21 January 2018

Rapid virologic response: a new milestone in the management of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.00995.X

21 January 2018

Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)/ribavirin therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.00995.X

21 January 2018

Predictive value of rapid virological response and early virological response on sustained virological response in HCV patients treated with pegylated interferon alpha-2a and ribavirin.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.00995.X

21 January 2018

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.00995.X

21 January 2018

Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.00995.X

21 January 2018

Hepatitis C virus RNA kinetics during the initial 12 weeks treatment with pegylated interferon-alpha 2a and ribavirin according to virological response

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.00995.X

21 January 2018

Twice-daily administration of interferon-beta for chronic hepatitis C is not superior to a once-daily regimen

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.00995.X

21 January 2018

Possible mechanisms of elevation of serum transaminase levels during interferon-beta therapy in chronic hepatitis C patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.00995.X

21 January 2018

Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.00995.X

21 January 2018

Identifiers

10.1111/J.1872-034X.2012.00995.X

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/22487191

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/22487191

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50552508&oldid=1540637171"